Elicera Therapeutics AB

Suède

Commandez votre montre hebdomadaire Elicera Therapeutics AB
Quantité totale PI 7
Rang # Quantité totale PI 226 803
Note d'activité PI 1,3/5.0    4
Rang # Activité PI 241 943
Symbole boursier
ISIN SE0015382080
Capitalisation 58.4M  (SEK)

Brevets

Marques

4 0
1 0
2 0
0
 
Dernier brevet 2024 - Adenovirus for treatment of cancer
Premier brevet 2013 - Hexon tat-ptd modified adenoviru...

Derniers inventions, produits et services

2022 Invention Adenovirus for treatment of cancer. The invention relates to an adenovirus comprising a nucleic ...
Invention Adenovirus for treatment of cancer. The invention relates to an adenovirus comprising a nucleic a...
2021 Invention Anti-il13r-alpha2 antibodies, antigen-binding fragments and uses thereof. The invention relates ...
Invention Anti-il13rα2 antibodies, antigen-binding fragments and uses thereof. The invention relates to ant...
Invention Anti-il13r.alpha.2 antibodies, antigen-binding fragments and uses thereof. The invention relates ...
2016 Invention T-cell immunotherapy. T-cells useful in T-cell immunotherapy comprise a CAR, TCR and/or nucleic ...
2013 Invention Hexon tat-ptd modified adenovirus and uses thereof. The invention provides a hexon Tat-PTD modifi...